Wells Fargo’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Buy |
18,100
+3,230
| +22% | +$21.7K | ﹤0.01% | 4679 |
|
|
2025
Q1 | $134K | Buy |
14,870
+127
| +0.9% | +$1.15K | ﹤0.01% | 4488 |
|
|
2024
Q4 | $255K | Buy |
14,743
+3,357
| +29% | +$58K | ﹤0.01% | 4166 |
|
|
2024
Q3 | $182K | Buy |
11,386
+487
| +4% | +$7.78K | ﹤0.01% | 4257 |
|
|
2024
Q2 | $155K | Buy |
10,899
+3,302
| +43% | +$47.1K | ﹤0.01% | 4319 |
|
|
2024
Q1 | $108K | Buy |
7,597
+970
| +15% | +$13.7K | ﹤0.01% | 4480 |
|
|
2023
Q4 | $100K | Buy |
6,627
+1,300
| +24% | +$19.6K | ﹤0.01% | 4493 |
|
|
2023
Q3 | $84.2K | Sell |
5,327
-2,853
| -35% | -$45.1K | ﹤0.01% | 4546 |
|
|
2023
Q2 | $124K | Buy |
8,180
+8,011
| +4,740% | +$121K | ﹤0.01% | 4643 |
|
|
2023
Q1 | $2.45K | Buy |
169
+1
| +0.6% | +$15 | ﹤0.01% | 5873 |
|
|
2022
Q4 | $2.27K | Buy |
168
+3
| +2% | +$41 | ﹤0.01% | 5656 |
|
|
2022
Q3 | $3K | Buy |
165
+52
| +46% | +$945 | ﹤0.01% | 5753 |
|
|
2022
Q2 | $2K | Sell |
113
-2,172
| -95% | -$38.4K | ﹤0.01% | 6083 |
|
|
2022
Q1 | $21K | Sell |
2,285
-3,035
| -57% | -$27.9K | ﹤0.01% | 5655 |
|
|
2021
Q4 | $91K | Buy |
+5,320
| New | +$91K | ﹤0.01% | 5281 |
|